Ligand profile
C09
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2684 — ribosyldihydronicotinamide dehydrogenase (quinone)
Identifiers
Database identifiers and provenance.
- Ligand ID
C09- PDB
5lbu- UniProt (similar protein)
P16083- Target protein
- VK055_2684
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 76.8
- −1 ≤ LogP ≤ 5 2.23
- MW ≤ 500 Da 242.3
- LogP ≤ 5 2.23
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 76.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCOCc1[nH]c2c3ccccc3nc(c2n1)NCCOCc1[nH]c2c3ccccc3nc(c2n1)N
InChI=1S/C13H14N4O/c1-2-18-7-10-16-11-8-5-3-4-6-9(8)15-13(14)12(11)17-10/h3-6H,2,7H2,1H3,(H2,14,15)(H,16,17)InChI=1S/C13H14N4O/c1-2-18-7-10-16-11-8-5-3-4-6-9(8)15-13(14)12(11)17-10/h3-6H,2,7H2,1H3,(H2,14,15)(H,16,17)
DEVCLHVFELRPIU-UHFFFAOYSA-NDEVCLHVFELRPIU-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02525
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand C09 →
- PDB RCSB structure 5lbu →
- UniProt UniProt P16083 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “C09”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2684.
PDB 59
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).